Table 1.
Fragmentation of EcLon by proteolytic enzymes of different specificity
Domain or fragment | Chymotrypsin (present study) | Trypsina | Glutamyl endopeptidaseb | ||||
---|---|---|---|---|---|---|---|
No. Nuc (+/− Mg2+) | ATP/ADP | ATP/ADP (+ Mg2+) | No. Nuc (+ Mg2+) | ATP/ADP (+ Mg2+) | No. Nucd (+/− Mg2+) | ATP/ADP (+/− Mg2+) | |
N | 1–207 | 1–207 | 1–207 | 1/6–235/239 | 1/6–235/239 | 5–240 | 5–240 |
A | 235–584 | 235–584 | |||||
AP | 235–784 | 236/240–784C | 236/240–784 | 241–784 | |||
α | 491–584 | ||||||
αP | 490–784 | 487–784 | |||||
P | 585–784 | 585–784 | 585–784 |
Nue - nucleotides.
According to literature data (Patterson et al., 2004; Vasilyeva et al., 2002). Some incorrect numbers of amino-acid residues flanking the corresponding tryptic fragments were changed according to the sequencing data presented in the same paper (Patterson et al., 2004).
Unstable intermediate fragment.
identical results were obtained in the presence of non-hydrolyzable ATP analogs or non-adenosine nucleotides.